Robin Robinson
Algemeen Directeur bij Esperovax, Inc.
Profiel
Robin A.
Robinson is currently the President & Chief Executive Officer at Esperovax, Inc. Prior to this, he was the Chief Scientific Officer at RenovaCare, Inc. He has also served as the Director of Biomedical Advanced Research & Development Authority from 2008 to 2016.
Earlier in his career, he worked as the Vaccines Director at Novavax, Inc. from 1995 to 2004.
Additionally, he held the position of Assistant Professor at The University of Texas Southwestern Medical Center.
Actieve functies van Robin Robinson
| Bedrijven | Functie | Begin |
|---|---|---|
Esperovax, Inc.
 Esperovax, Inc. Pharmaceuticals: MajorHealth Technology Esperovax, Inc. develops capsule vaccines. The company is based in Plymouth, MI. The company was founded by David O'Hagan, Roger S. Newton, Savita Nikam. Robin A. Robinson has been the CEO of the company since 2023. | Algemeen Directeur | 01-05-2023 |
Eerdere bekende functies van Robin Robinson
| Bedrijven | Functie | Einde |
|---|---|---|
| RENOVACARE, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2023 |
| Biomedical Advanced Research & Development Authority | Directeur/Bestuurslid | 01-01-2016 |
| NOVAVAX, INC. | Corporate Officer/Principal | 01-01-2004 |
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| RENOVACARE, INC. | Health Technology |
| NOVAVAX, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Biomedical Advanced Research & Development Authority | |
Esperovax, Inc.
Esperovax, Inc. Pharmaceuticals: MajorHealth Technology Esperovax, Inc. develops capsule vaccines. The company is based in Plymouth, MI. The company was founded by David O'Hagan, Roger S. Newton, Savita Nikam. Robin A. Robinson has been the CEO of the company since 2023. | Health Technology |
